Indian generic drugmakers set for weekly drop on potential US pharma policy changes
Shares of Indian generic drugmakers down between 2% to 5% this week
Sun Pharmaceuticals SUN.NS down 4.8% this week, set for sharpest weekly drop since June 2022
U.S. President Donald Trump signed an executive order on Monday that aims to reduce the time it takes to approve pharmaceutical plants in the country
Cipla CIPL.NS and Dr Reddy's Laboratories REDY.NS down 3.49% and ~2% this week, respectively
The three drugmakers, having a combined 46% weightage on the pharma index .NIPHARM, get between 30% to 40% of revenue from North America
Pharma index is down 2.7% this week
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora

POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now

Amazon vs. Microsoft: Which Stock Is a Better Buy for 2026 and Beyond?

Palantir Q1 2026 Earnings Preview — Is PLTR a Buy at $144?

Tradingkey





